Cancer-associated thrombosis (CAT) by John-Bjarne Hansen, (Coordinating Author)

Get full text

VTE epidemiology and challenges for VTE prevention at the population level by Sigrid K. Brækkan, John-Bjarne Hansen

Get full text

Optimized workflow to modify microRNA expression in primary human intravascular cells by Safak Caglayan, John-Bjarne Hansen, Omri Snir

Get full text

Sustained and intermittent hypoxia differentially modulate primary monocyte immunothrombotic responses to IL-1β stimulation by Casper J.E. Wahlund, Safak Çaglayan, Paulo Czarnewski, Paulo Czarnewski, John-Bjarne Hansen, John-Bjarne Hansen, Omri Snir, Omri Snir

Get full text

White blood cell count measured prior to cancer development is associated with future risk of venous thromboembolism--the Tromsø study. by Kristine Blix, Hilde Jensvoll, Sigrid K Brækkan, John-Bjarne Hansen

Get full text

Surgery As a Trigger for Incident Venous Thromboembolism: Results from a Population-Based Case-Crossover Study by Dana Meknas, Sigrid K. Brækkan, John-Bjarne Hansen, Vânia M. Morelli

Get full text

Platelet count and risk of major bleeding in venous thromboembolism by Håkon S. Johnsen, Sigrid K. Braekkan, Vânia M. Morelli, John-Bjarne Hansen

Get full text

Impact of red cell distribution width on future risk of cancer and all-cause mortality among cancer patients – the Tromsø Study by Trygve S. Ellingsen, Jostein Lappegård, Tove Skjelbakken, Sigrid K. Brækkan, John-Bjarne Hansen

Get full text

D-dimer measured at first venous thromboembolism is associated with future risk of cancer by Olga V. Gran, Sigrid K. Brækkan, Benedikte Paulsen, Hanne Skille, John-Bjarne Hansen

Get full text

Cystatin C is associated with risk of venous thromboembolism in subjects with normal kidney function – the Tromsø study by Ellen E. Brodin, Sigrid K. Brækkan, Anders Vik, Jan Brox, John-Bjarne Hansen

Get full text

Hematocrit and risk of venous thromboembolism in a general population. The Tromsø study by Sigrid K. Brækkan, Ellisiv B. Mathiesen, Inger Njølstad, Tom Wilsgaard, John-Bjarne Hansen

Get full text

Neutrophil to lymphocyte ratio and future risk of venous thromboembolism and mortality: the Tromsø Study by Gro Grimnes, Lars D. Horvei, Vladimir Tichelaar, Sigrid K. Brækkan, John-Bjarne Hansen

Get full text

Plasma hepcidin is associated with future risk of venous thromboembolism by Trygve S. Ellingsen, Jostein Lappegård, Thor Ueland, Pål Aukrust, Sigrid K. Brækkan, John-Bjarne Hansen

Get full text

Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study by Stein Harald Johnsen, Bjarne K. Jacobsen, Sigrid K. Brækkan, John-Bjarne Hansen, Ellisiv B. Mathiesen

Get full text

Impact of respiratory symptoms and oxygen saturation on the risk of incident venous thromboembolism—the Tromsø study by Trond Børvik, Line H. Evensen, Vania M. Morelli, Hasse Melbye, Sigrid K. Brækkan, John‐Bjarne Hansen

Get full text

Hand grip strength and risk of incident venous thromboembolism: The Tromsø study by Oda G. R. Leknessund, Vania M. Morelli, Bjørn Heine Strand, John‐Bjarne Hansen, Sigrid K. Brækkan

Get full text

C-reactive protein and risk of venous thromboembolism: results from a population-based case-crossover study by Gro Grimnes, Trond Isaksen, Ynse Ieuwe Gerardus Vladimir Tichelaar, Jan Brox, Sigrid Kufaas Brækkan, John-Bjarne Hansen

Get full text

Plasma procoagulant phospholipid clotting time and venous thromboembolism risk by Cathrine Ramberg, Line Wilsgård, Nadezhda Latysheva, Sigrid K. Brækkan, Kristian Hindberg, Timofey Sovershaev, Omri Snir, John‐Bjarne Hansen

Get full text

High-sensitivity C-reactive protein is not a risk factor for venous thromboembolism: the Tromsø study by Erin M. Hald, Sigrid K. Brækkan, Ellisiv B. Mathiesen, Inger Njølstad, Tom Wilsgaard, Jan Brox, John-Bjarne Hansen

Get full text

Diagnostic Blood Biomarkers for Acute Pulmonary Embolism: A Systematic Review by Vårin Eiriksdatter Wikan, Birgitte Gladsø Tøndel, Vânia Maris Morelli, Ellen Elisabeth Brodin, Sigrid Kufaas Brækkan, John-Bjarne Hansen

Get full text